UNITED STATES SECURITIES AND EXCHANGE COMMISSION ----------------------
FORM 4 Washington, D.C. 20549 | OMB APPROVAL |
|---------------------|
| OMB Number: |
{} Check this box if STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 3235-0287 |
no longer subject to | Expires: |
Section 16. Form 4 or | November 30, 2011 |
Form 5 obligations may | Estimated average |
continue. See Instruction | burden hours per |
1(b). | response 0.5 |
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section -----------------------
17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the
(Print or Type Responses) Investment Company Act of 1940
---------------------------------------------------------------------------------------------------------------------------------
|1. Name and Address of | 2. Issuer Name and Ticker or Trading Symbol | 5. Relationship of Reporting Person(s) |
| Reporting Person* | | to Issuer (Check all applicable) |
|Troendle August J. |Medpace Holdings, Inc. MEDP | __X__ Director __X__ 10% Owner |
| | | __X__ Officer _____ Other |
|--------------------------|---------------------------------------------------|
|(Last) (First) (Middle)|3. Date of Earliest Transaction (Month/Day/Year) | (give title below) (specify below)|
| | 04-29-2024 |CEO |
|C/O MEDPACE HOLDINGS, INC.|---------------------------------------------------| |
|,5375 MEDPACE WAY | | |
| (Street) |4.If Amendment, Date Original Filed(Month/Day/Year)|-------------------------------------------------|
| | | 6. Individual or Joint/Group Filing |
|CINCINNATI - OH - 45227 | | (Check Applicable Line) |
| (City) (State) (Zip) | | _X_ Form filed by One Reporting Person |
| | | ___ Form filed by More than One |
| | | Reporting Person |
---------------------------------------------------------------------------------------------------------------------------------
Table I -- Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
------------------------------------------------------------------------------------------------------------------------
| 1. | 2. | 2a. | 3. | 4. | 5. | 6. | 7. |
| Title of | Trans- | Deemed | Transaction | Securities Acquired | Amount of Sec | Ownership | Nature of |
| Security | action | Execut. | Code | (A) or Disposed of (D) | Beneficially | Form: | Indirect |
| (Instr. 3) | Date | Date | (Instr. 8) | (Instr. 3, 4 and 5) |Owned Following| Direct | Beneficial |
| |----------|----------|---------|----|----------|-----|--------| Transaction(s)| (D) or | Ownership |
| | (Month/ | (Month/ | | | | (A) | | | Indirect | (Instr. 4) |
| | Day/ | Day/ | | | | or | | (Instr. 3 and | (I) | |
| | Year) | Year) | Code | V | Amount | (D) | Price | 4) | Instr. 4) | |
---------------------------------------------------------------------------------|-----------------------------------------------
|Common Stock |04-29-2024| |S | |15,102 |D |$400.69 |791,541 |D | |
| | | |#1 | | | |#2 | | | |
|--------------------------------------------------------------------------------|-----------------------------------------------|
|Common Stock |04-30-2024| |S | |1,828 |D |$400.31 |789,713 |D | |
| | | |#1 | | | |#3 | | | |
|--------------------------------------------------------------------------------|-----------------------------------------------|
|Common Stock | | | | | | | |4,733,019 |I |By Medpace Investo|
| | | | | | | | | | |rs, LLC |
| | | | | | | | | | |#4 |
|--------------------------------------------------------------------------------|-----------------------------------------------|
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
----------------------------------------------------------------------------------------------------------------------------------
|1. |2. | 3. | 3a. |4. | 5. | 6. | 7. |8. |9. |10. |11. |
|Title of|Conver- | Trans- | Deemed |Trans- | Number of | Date | Title and |Price |Number |Owner- |Nature of|
|Deriv- |sion or | action | Execu. |action | Deriv- | Exercisable | Amount of |of |of |ship |Indirect |
|ative |Exercise| Date | Date |Code | ative | and Expira- | Underlying |Deriv- |Deriv- |Form |Benefici.|
|Security|Price of| (Month/ | (Month/ |(Instr.| Securities | tion Date | Securities |ative |ative |of |Ownership|
|(Instr. |Deriv- | Day/ | Day/ |8) | Acquired | (Month/Day/ | (Instr. 3 |Secur- |Secur- |Deriv- |(Instr. 4|
| 3) |ative | Year) | Year) | | (A) or | Year) | and 4) |ity |ities |ative | |
| |Security| | | | Disposed of |----------------|--------------|(Instr.|Bene- |Secur- | |
| | | | |-------| (D) (Instr. | | | | | 5) |ficially|ity | |
| | | | | | | 3, 4 and 5) | | | |Amount | |Owned |Direct | |
| | | | | | |--------------| | | |or | |folowing|(D) or | |
| | | | | | | | |Date |Expira- | |Number | |reported|Indirect| |
| | | | | | | | |Exer- |tion | |of | |tran.(s)|(I) | |
| | | | |Code| V| (A) | (D) |cisable|Date |Title |Shares | |(Inst.4)|Instr. 4| |
----------------------------------------------------------------------------------------------------------------------------------
+----------------------------------------------------------------------------------+
| | Relationships |
| Reporting Owner Name / Address +----------+----------+----------+-------- -+
| | Director |10% Owner | Officer | Other |
+--------------------------------------+----------+----------+----------+----------+
|Troendle August J. | X | X |CEO | |
|C/O MEDPACE HOLDINGS, INC. | | | | |
|5375 MEDPACE WAY | | | | |
|CINCINNATI OH 45227 | | | | |
|--------------------------------------+----------+----------+----------+----------|
Explanation of Responses:
1 The transactions reported on this Form 4 were effected pursuant to a limit order pl
aced by the Reporting Person during an open window period.
2 The reported price is a weighted average price. These shares were sold in multiple
transactions ranging from $400.00 to $402.82. The Reporting Person undertakes to pro
vide full pricing information
to the Issuer, any security holder of the Issuer or th
e staff of the Securities and Exchange Commission upon request.
3 The reported price is a weighted average price. These shares were sold in multiple
transactions ranging from $400.00 to $400.92. The Reporting Person undertakes to pro
vide full pricing information
to the Issuer, any security holder of the Issuer or th
e staff of the Securities and Exchange Commission upon request.
4 The Reporting Person is the sole manager and controlling unit holder of Medpace Inv
estors, LLC ("MPI") and has sole voting and investment control with respect to the s
ecurities held by MPI. The Reporting Person may be deemed to indirectly beneficially
own the securities of the Issuer held by MPI but disclaims beneficial ownership of su
ch securities except to the extent of his pecuniary interest therein.
Remarks:
Signatures
/s/ Stephen P. Ewald, Attorney-in-Fact for August J. Troendl / 05-01-2024
e
------------------------------------------------------------- -----------
** Signature of Reporting Person Date
* If the form is filed by more than one reporting person, seeInstruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.
Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.